July 30, 2014 8:48 PM ET

Capital Markets

Company Overview of Aisling Capital

Executive Profile

Anthony Y. Sun M.D.

AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships


Dr. Anthony Y. Sun, M.D., is a Partner at Aisling Capital. Dr. Sun has been at Perseus-Soros Biopharmaceutical Fund LP since 2001 and is its Partner. Prior to joining Perseus-Soros, Dr. Sun was an entrepreneur co-founding a disease management company for patients on blood thinners. In addition, he was an Adjunct Instructor of Medicine at the Hospital of the University of Pennsylvania. Dr. Sun serves as a Director of CeNeRx BioPharma, Inc., Dynova Laboratories, Inc., ...

Corporate Headquarters

888 Seventh Avenue
New York, New York 10106

United States

Phone: 212-651-6380
Fax: 212-651-6379

Board Members Memberships

Former Director
Former Director
Director and Member of Audit Committee


Cornell University
University of Pennsylvania - The Wharton School
Temple University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aisling Capital, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.